KMT2A and B-cell chronic lymphocytic leukemia: PRMT5 regulates oncogenes such as NOTCH1, c-MYC, P53, and MLL–AF943 that are often dysregulated in RT; thus, we hypothesized PRMT5 may be a unifying driver contributing to CLL progression to RT.